Literature DB >> 16300851

Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems.

Xiaosong Luan1, Roland Bodmeier2.   

Abstract

The objective was to investigate the influence of poly(lactide-co-glycolide) (PLGA) type (molecular weight and end-group functionality) on the leuprolide release from in situ forming microparticle (ISM) systems. ISM systems are based on an emulsion of the PLGA solution dispersed in an oil phase. The polymer droplets solidify after contact with aqueous fluids and form microparticles in situ. In contrast to microparticles prepared by the classical solvent evaporation method, the use of the lower molecular weight PLGA resulted in ISM with a lower initial release than ISM prepared with the higher molecular weight PLGA. ISM prepared with PLGA combinations showed a decreasing initial release with increasing low-molecular-weight PLGA content. A slower solvent diffusion from the low-molecular-weight PLGA solution droplets into the release medium led to a less porous structure of the resulting microparticles, thus explaining the lower initial release. PLGA with free carboxylic acid end groups led to a lower drug release compared to PLGA with esterified end groups. 6-month controlled release leuprolide ISM could be obtained by blending poly(lactides) (PLA) with different molecular weights.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16300851     DOI: 10.1016/j.jconrel.2005.10.005

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  12 in total

Review 1.  Long-term delivery of protein therapeutics.

Authors:  Ravi Vaishya; Varun Khurana; Sulabh Patel; Ashim K Mitra
Journal:  Expert Opin Drug Deliv       Date:  2014-09-24       Impact factor: 6.648

2.  Characterization of formulation parameters affecting low molecular weight drug release from in situ forming drug delivery systems.

Authors:  Ravi B Patel; Angela N Carlson; Luis Solorio; Agata A Exner
Journal:  J Biomed Mater Res A       Date:  2010-08       Impact factor: 4.396

3.  The anti-melanoma efficiency of the intratumoral injection of cucurbitacin-loaded sustained release carriers: in situ-forming implants.

Authors:  Jianbo Guo; Junwei Wang; Chenchen Cai; Jinghua Xu; Hongdan Yu; Hui Xu; Tang Xing
Journal:  AAPS PharmSciTech       Date:  2015-01-22       Impact factor: 3.246

4.  Development of an enhanced formulation for delivering sustained release of buprenorphine hydrochloride.

Authors:  S Koocheki; S S Madaeni; P Niroomandi
Journal:  Saudi Pharm J       Date:  2011-05-12       Impact factor: 4.330

5.  Noninvasive characterization of in situ forming implants using diagnostic ultrasound.

Authors:  Luis Solorio; Brett M Babin; Ravi B Patel; Justyna Mach; Nami Azar; Agata A Exner
Journal:  J Control Release       Date:  2010-01-11       Impact factor: 9.776

6.  Formulation and evaluation of PLA and PLGA in situ implants containing secnidazole and/or doxycycline for treatment of periodontitis.

Authors:  Heba A Gad; Mohamed A El-Nabarawi; Seham S Abd El-Hady
Journal:  AAPS PharmSciTech       Date:  2008-07-25       Impact factor: 3.246

7.  Application of hydroxyapatite nanoparticles in development of an enhanced formulation for delivering sustained release of triamcinolone acetonide.

Authors:  Saeid Koocheki; Sayed Siavash Madaeni; Parisa Niroomandi
Journal:  Int J Nanomedicine       Date:  2011-04-19

8.  In-vitro/In-vivo comparison of leuprolide acetate release from an in-situ forming plga system.

Authors:  Roya Mashayekhi; Hamid Mobedi; Jamal Najafi; Marjan Enayati
Journal:  Daru       Date:  2013-07-15       Impact factor: 3.117

9.  A biodegradable polymeric system for peptide-protein delivery assembled with porous microspheres and nanoparticles, using an adsorption/infiltration process.

Authors:  Sergio Alcalá-Alcalá; Zaida Urbán-Morlán; Irene Aguilar-Rosas; David Quintanar-Guerrero
Journal:  Int J Nanomedicine       Date:  2013-06-10

10.  Noninvasive characterization of the effect of varying PLGA molecular weight blends on in situ forming implant behavior using ultrasound imaging.

Authors:  Luis Solorio; Alexander M Olear; Jesse I Hamilton; Ravi B Patel; Ashlei C Beiswenger; Jon E Wallace; Haoyan Zhou; Agata A Exner
Journal:  Theranostics       Date:  2012-11-08       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.